{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:58:20Z","timestamp":1787025500292,"version":"build-2736575974"},"reference-count":42,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"32","license":[{"start":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T00:00:00Z","timestamp":1375920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,8]]},"abstract":"<jats:p>In 2007 in Navarre, Spain, universal varicella vaccination with two doses of Varivax was introduced in the childhood immunisation schedule for children aged 15 months and three years. This study describes changes in the epidemiology of varicella in the period 2006 to 2012 and evaluates vaccination effectiveness using epidemiological surveillance data. The incidence of varicella in children aged 0 to 14 years decreased by 98.1%, from 50.1 cases per 1,000 inhabitants in 2006, to 1.0 per 1,000 in 2012. Children aged one to eight years were the vaccinated cohorts, and their incidence of varicella decreased by 98.5% (p&lt;0.0001). In unvaccinated age groups, important reductions were also achieved between 2006 and 2012: 90.5% (p&lt;0.0001) in infants under one year of age, and 89.4% (p&lt;0.0001) in children aged nine years. In the period 2006 to 2012, the hospital admissions rate for varicella or its complications decreased by 89.0%, and in 2012, there was only one admission of a newborn with neonatal varicella. Vaccine effectiveness for at least one dose was 96.8% (95% confidence interval: 96.3-97.2%). Universal vaccination with two doses has reduced varicella circulation to minimum levels within five years and has proved highly effective.<\/jats:p>","DOI":"10.2807\/1560-7917.es2013.18.32.20552","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T11:09:10Z","timestamp":1375960150000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":39,"title":["Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012"],"prefix":"10.2807","volume":"18","author":[{"given":"M","family":"Garc\u00eda Cenoz","sequence":"first","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Pamplona, Spain"},{"name":"Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Castilla","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain"},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Chamorro","sequence":"additional","affiliation":[{"name":"Complejo Hospitalario Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Mart\u00ednez-Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain"},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Mart\u00ednez-Artola","sequence":"additional","affiliation":[{"name":"Complejo Hospitalario Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Irisarri","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Pamplona, Spain"},{"name":"Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arriazu","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain"},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ezpeleta","sequence":"additional","affiliation":[{"name":"Complejo Hospitalario Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Barricarte","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Pamplona, Spain"},{"name":"Instituto de Salud P\u00fablica de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7995","reference":[{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref01","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69561-5"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref02","unstructured":"Varicella vaccines. WHO position paper. Wkly Epidemiol Rec. 1998;73(32):241-8. PMid:9715106"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref03","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000232631.06763.8b"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref04","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40. PMid:17585291"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref05","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196208232670801"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref06","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.606"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref07","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2005.02.003"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref08","doi-asserted-by":"publisher","DOI":"10.1086\/522145"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref09","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2005.00717.x"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.01.036"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref11","doi-asserted-by":"crossref","unstructured":"Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15(13):pii=19530. Available from: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19530","DOI":"10.2807\/ese.15.13.19530-en"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.022"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.7.851"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq081"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref15","doi-asserted-by":"crossref","unstructured":"Fox J, Elveback L, Scott W, Gatewood L, Ackerman E. Herd immunity: basic concept end relevance to public health immunization practices. Am J Epidemiol. 1971;94(3):179-89. PMid:5093648","DOI":"10.1093\/oxfordjournals.aje.a121310"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.3.463"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref17","unstructured":"Orden Foral 19\/2008, de 15 de febrero, de la Consejer\u00eda de Salud, por la que se modifican las enfermedades incluidas en el Sistema de Vigilancia Epidemiol\u00f3gica de Navarra. [Local Order 19\/2008, of 15 February, of the Ministry of Health, amending the diseases included in the Epidemiological Surveillance System of Navarra]. Bolet\u00edn Oficial de Navarra. 2008:28. Spanish. Available from: http:\/\/sid.usal.es\/leyes\/discapacidad\/12504\/3-2-3\/orden-foral-19-2008-de-15-de-febrero-de-la-consejera-de-salud-por-la-que-se-modifican-las-enfermedades-incluidas-en-el-sistema-de-vigilancia-epidemiol.aspx"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref18","unstructured":"Wonca International Classification Committee (WICC). International Classification of Primary Care \u2013 2nd Edition (ICPC-2). Bangkok: World Organization of Family Doctors (Wonca). [Accessed 10 Oct 2012]. Available from: http:\/\/www.rivm.nl\/who-fic\/cdromthesaurus\/Pagerenglish.pdf"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref19","unstructured":"CIE9MC. Clasificaci\u00f3n Internacional de Enfermedades, 9\u00aa Revisi\u00f3n Modificaci\u00f3n Cl\u00ednica. [International Classification of Diseases, 9th Revision Clinical Modification]. 8th ed. Madrid: Ministerio de Sanidad, Pol\u00edtica Social e Igualdad, Secretar\u00eda General T\u00e9cnica; 2012. Available from http:\/\/www.msc.es\/estadEstudios\/estadisticas\/docs\/CIE9MC_8ed.pdf"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-09"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref21","unstructured":"National Statistics Institute (NSI). Population figures by Municipalities, Islands, Provinces and Autonomous Communities Madrid: NSI. [Accessed 18 Dec 2012]. Available from: http:\/\/www.ine.es\/jaxi\/menu.do?type=pcaxis&amp;path=%2Ft20%2Fe260&amp;file=inebase&amp;L=1"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/22.4.742"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.10.021"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref24","doi-asserted-by":"publisher","DOI":"10.1590\/S0021-75572009000400016"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq052"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.7.797"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0012"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.08.016"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir660"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref30","doi-asserted-by":"crossref","unstructured":"Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine. Pediatrics. 1993;92(6):833-7. PMid:8233746","DOI":"10.1542\/peds.92.6.833"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00100-6"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref32","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268809990860"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref33","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181d9f657"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.079"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref35","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000109287.97518.67"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref36","doi-asserted-by":"crossref","unstructured":"Hope-Simpson RE. The Nature of Herpes Zoster: a Long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20. PMid:14267505 PMCid:PMC1898279","DOI":"10.1177\/003591576505800106"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00180-9"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09837-9"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref39","doi-asserted-by":"crossref","unstructured":"Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol. 2003;70 Suppl 1(1):S31-7.","DOI":"10.1002\/jmv.10317"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.024"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir436"},{"key":"10.2807\/1560-7917.ES2013.18.32.20552_ref42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.5.1000"}],"container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T06:46:42Z","timestamp":1663224402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES2013.18.32.20552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,8]]},"references-count":42,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2013,8,8]]}},"URL":"https:\/\/doi.org\/10.2807\/1560-7917.es2013.18.32.20552","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,8]]}}}